BKD may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 35 of 42 cases where BKD's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 83%.
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where BKD's RSI Indicator exited the oversold zone, 24 of 32 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 75%.
The Momentum Indicator moved above the 0 level on October 29, 2026. You may want to consider a long position or call options on BKD as a result. In 68 of 86 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 79%.
The Moving Average Convergence Divergence (MACD) for BKD just turned positive on October 21, 2026. Looking at past instances where BKD's MACD turned positive, the stock continued to rise in 38 of 53 cases over the following month. The odds of a continued upward trend are 72%.
Following a +4.11% 3-day Advance, the price is estimated to grow further. Considering data from situations where BKD advanced for three days, in 228 of 292 cases, the price rose further within the following month. The odds of a continued upward trend are 78%.
The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BKD declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 76%.
The Aroon Indicator for BKD entered a downward trend on October 30, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Valuation Rating of 6 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-85.636) is normal, around the industry mean (204.120). P/E Ratio (-17.610) is within average values for comparable stocks, (19.084). Projected Growth (PEG Ratio) (0.080) is also within normal values, averaging (2.498). Dividend Yield (0.096) settles around the average of (0.091) among similar stocks. P/S Ratio (0.916) is also within normal values, averaging (2.688).
The Tickeron PE Growth Rating for this company is 17 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 62 (best 1 - 100 worst), indicating fairly steady price growth. BKD’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 64 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 84, placing this stock slightly better than average.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The RSI Oscillator for SNDA moved out of oversold territory on October 28, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 25 similar instances when the indicator left oversold territory. In 23 of the 25 cases the stock moved higher. This puts the odds of a move higher at 90%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 49 of 65 cases where SNDA's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 75%.
The Moving Average Convergence Divergence (MACD) for SNDA just turned positive on October 30, 2026. Looking at past instances where SNDA's MACD turned positive, the stock continued to rise in 33 of 47 cases over the following month. The odds of a continued upward trend are 70%.
Following a +2.08% 3-day Advance, the price is estimated to grow further. Considering data from situations where SNDA advanced for three days, in 201 of 277 cases, the price rose further within the following month. The odds of a continued upward trend are 73%.
SNDA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where SNDA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 72%.
The Aroon Indicator for SNDA entered a downward trend on October 30, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron PE Growth Rating for this company is 26 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 59 (best 1 - 100 worst), indicating fairly steady price growth. SNDA’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 94 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SNDA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 84, placing this stock worse than average.
The Tickeron Valuation Rating of 95 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.913) is normal, around the industry mean (204.120). P/E Ratio (-6.049) is within average values for comparable stocks, (19.084). SNDA's Projected Growth (PEG Ratio) (16.640) is very high in comparison to the industry average of (2.498). Dividend Yield (0.000) settles around the average of (0.091) among similar stocks. P/S Ratio (2.028) is also within normal values, averaging (2.688).
The Tickeron SMR rating for this company is 97 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
BKD | SNDA | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 50 | 50 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 6 Undervalued | 95 Overvalued | |
PROFIT vs RISK RATING 1..100 | 64 | 94 | |
SMR RATING 1..100 | 100 | 97 | |
PRICE GROWTH RATING 1..100 | 62 | 59 | |
P/E GROWTH RATING 1..100 | 17 | 26 | |
SEASONALITY SCORE 1..100 | n/a | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
BKD's Valuation (6) in the Hospital Or Nursing Management industry is significantly better than the same rating for SNDA (95). This means that BKD’s stock grew significantly faster than SNDA’s over the last 12 months.
BKD's Profit vs Risk Rating (64) in the Hospital Or Nursing Management industry is in the same range as SNDA (94). This means that BKD’s stock grew similarly to SNDA’s over the last 12 months.
SNDA's SMR Rating (97) in the Hospital Or Nursing Management industry is in the same range as BKD (100). This means that SNDA’s stock grew similarly to BKD’s over the last 12 months.
SNDA's Price Growth Rating (59) in the Hospital Or Nursing Management industry is in the same range as BKD (62). This means that SNDA’s stock grew similarly to BKD’s over the last 12 months.
BKD's P/E Growth Rating (17) in the Hospital Or Nursing Management industry is in the same range as SNDA (26). This means that BKD’s stock grew similarly to SNDA’s over the last 12 months.
| BKD | SNDA | |
|---|---|---|
| RSI ODDS (%) | 3 days ago 75% | 3 days ago 90% |
| Stochastic ODDS (%) | 3 days ago 71% | 3 days ago 75% |
| Momentum ODDS (%) | 3 days ago 79% | N/A |
| MACD ODDS (%) | 3 days ago 72% | 3 days ago 70% |
| TrendWeek ODDS (%) | 3 days ago 77% | 3 days ago 73% |
| TrendMonth ODDS (%) | 3 days ago 78% | 3 days ago 68% |
| Advances ODDS (%) | 3 days ago 78% | 3 days ago 73% |
| Declines ODDS (%) | 6 days ago 76% | 6 days ago 72% |
| BollingerBands ODDS (%) | 3 days ago 83% | 3 days ago 83% |
| Aroon ODDS (%) | 3 days ago 75% | 3 days ago 63% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
BKD’s FA Score shows that 2 FA rating(s) are green while SNDA’s FA Score has 1 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
BKD’s TA Score shows that 5 TA indicator(s) are bullish while SNDA’s TA Score has 5 bullish TA indicator(s).
BKD (@Hospital/Nursing Management) experienced а +3.08% price change this week, while SNDA (@Hospital/Nursing Management) price change was +1.42% for the same time period.
The average weekly price growth across all stocks in the @Hospital/Nursing Management industry was +0.92%. For the same industry, the average monthly price growth was +4.04%, and the average quarterly price growth was +19.38%.
BKD is expected to report earnings on Nov 06, 2026.
SNDA is expected to report earnings on Nov 05, 2026.
Hospital/Nursing Management companies own and operate health care facilities. Their operations include nursing homes, acute care facilities, retirement centers and outpatient surgery centers. HCA Healthcare Inc., Alcon Inc. and Universal Health Services, Inc. are some major companies in this industry. Technology has been at the forefront of development of advanced solutions, including quicker diagnoses of complex conditions. Investments in new diagnostics, healthcare IoT, and other healthcare technologies continue to gather momentum in this industry.
A.I.dvisor indicates that over the last year, BKD has been loosely correlated with SNDA. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if BKD jumps, then SNDA could also see price increases.
| Ticker / NAME | Correlation To BKD | 1D Price Change % | ||
|---|---|---|---|---|
| BKD | 100% | +1.17% | ||
| SNDA - BKD | 42% Loosely correlated | +0.15% | ||
| THC - BKD | 25% Poorly correlated | +0.99% | ||
| AGL - BKD | 24% Poorly correlated | -1.21% | ||
| AVAH - BKD | 24% Poorly correlated | -0.75% | ||
| CMPS - BKD | 24% Poorly correlated | -5.09% | ||
More | ||||
A.I.dvisor indicates that over the last year, SNDA has been loosely correlated with BKD. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if SNDA jumps, then BKD could also see price increases.
| Ticker / NAME | Correlation To SNDA | 1D Price Change % | ||
|---|---|---|---|---|
| SNDA | 100% | +0.15% | ||
| BKD - SNDA | 43% Loosely correlated | +1.17% | ||
| NHC - SNDA | 34% Loosely correlated | -2.84% | ||
| ADUS - SNDA | 26% Poorly correlated | +0.97% | ||
| EHC - SNDA | 26% Poorly correlated | +3.35% | ||
| PNTG - SNDA | 25% Poorly correlated | -1.93% | ||
More | ||||